Pharmacogenetics in cardiovascular disorders: An update on the principal drugs

Predazzi, I.; Mango, R.; Norata, Giuseppe; Di Daniele, N.; Sergi, D.; Romeo, F.; Novelli, G.

doi:10.1007/s40256-013-0020-9

Access Status

Fulltext not available

Authors

Predazzi, I.

Mango, R.

Norata, Giuseppe

Di Daniele, N.

Sergi, D.

Romeo, F.

Novelli, G.

Date

2013

Type

Journal Article

Metadata

Show full item record

Citation

Predazzi, I. and Mango, R. and Norata, G. and Di Daniele, N. and Sergi, D. and Romeo, F. and Novelli, G. 2013. Pharmacogenetics in cardiovascular disorders: An update on the principal drugs. American Journal of Cardiovascular Drugs. 13 (2): pp. 79-85.

Source Title

American Journal of Cardiovascular Drugs

DOI

10.1007/s40256-013-0020-9

ISSN

1175-3277

School

School of Biomedical Sciences

URI

http://hdl.handle.net/20.500.11937/55833

Collection

Curtin Research Publications

Abstract

In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful and useful to clinicians. Here, we briefly review the current state of the art on pharmacogenomics and its applications to modern cardiovascular medicine. © 2013 Springer International Publishing Switzerland.